Leading Japanese pharma company, Shionogi, joins Paddington Life Sciences Partners
Shionogi, one of Japan’s leading pharmaceutical companies, has joined Paddington Life Sciences Partners, the partnership group that brings together NHS, academic, industry and community organisations committed to building the Paddington Life Sciences cluster. Its arrival further strengthens WestTech London’s growing position as a centre for health and life sciences innovation.
Led by Imperial College Healthcare NHS Trust, Paddington Life Sciences is developing a new life sciences cluster centred around St Mary’s Hospital. Paddington Life Sciences Partners play a central role in this work, helping to accelerate research translation, support new health technologies and deliver social and economic value for the region.
Shionogi opened its UK office in Paddington in 2024, bringing more than 150 staff into the heart of the WestTech London cluster. The company is internationally recognised for its work in infectious diseases and antimicrobial resistance, and its membership places it alongside Imperial researchers leading major antimicrobial resistance programmes, including the Fleming Initiative. The Fleming Centre, opening on the St Mary’s Hospital campus in 2028, will become a key hub for antimicrobial resistance research and engagement.
Read more Read more about Leading Japanese pharma company, Shionogi, joins Paddington Life Sciences Partners
